Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DART trial of monitoring strategies and structured treatment interruptions for HIV in Africa
ISRCTN13968779Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Jan 2003
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of tenofovir disoproxil fumarate, nevirapine, abacavir, zidovudine and lamivudine in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (6 arms), sponsored by Medical Research Council. Primary endpoints: Efficacy and Safety. Started Jan 2003; status: completed.
02
Drugs
tenofovir disoproxil fumaratenevirapineabacavirzidovudinelamivudine
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ISRCTN13968779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13968779.